ACR 87 is a ceremonial, nonbinding concurrent resolution that directs legislative attention to amyotrophic lateral sclerosis and the burdens it places on individuals, families, and health systems. The text compiles disease facts, emphasizes diagnostic delays and costs to caregivers, and frames state policy priorities around access to treatments, prevention research, and support services.
Because the measure is a resolution—not a statute—it creates no new funding streams, regulatory duties, or enforceable rights. Its practical value lies in signaling priorities to agencies, funders, providers, and advocacy organizations rather than imposing operational requirements.
At a Glance
What It Does
The resolution proclaims May 2025 as Amyotrophic Lateral Sclerosis Awareness Month in California, lists factual findings about ALS, affirms five legislative commitments (access to treatments; identifying causes/risk factors; promoting participation; reducing burdens; ensuring quality supports), commends stakeholders, and directs the Chief Clerk to distribute copies.
Who It Affects
People living with ALS and their caregivers; researchers and clinical providers focused on neuromuscular disease; veterans' health programs (noting elevated veteran risk); state and local public health offices that may receive the proclamation; and advocacy and volunteer organizations that typically run awareness campaigns.
Why It Matters
Although symbolic, the resolution consolidates specific policy priorities into a clear public record—useful for grant-seekers, public health planners, and advocacy groups seeking legislative backing. It also enumerates prevalence and diagnostic-delay data that can justify programmatic attention, even though the resolution itself does not authorize spending or regulatory action.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
ACR 87 compiles a set of factual findings about ALS—its progressive neurodegeneration, typical two- to five-year life expectancy after diagnosis, worldwide distribution, and the substantial personal and financial burdens on patients and families. The text cites population estimates (roughly 2,400 Californians living with ALS at any time and an average of 5,600 U.S. diagnoses annually), notes a long diagnostic delay (over a year on average), and highlights that about 10 percent of cases have a known genetic driver and that veterans face heightened risk.
These findings are presented as the factual basis for the resolution's declaration.
Rather than creating legal mandates, the resolution declares May 2025 as ALS Awareness Month and then sets out five policy commitments: ensuring timely access to effective treatments, identifying causes and risk factors to prevent new cases, empowering people with ALS to remain engaged with the world, reducing physical/emotional/financial burdens, and ensuring high-quality services and supports for patients and caregivers. It also publicly commends the efforts of family members, caregivers, volunteers, researchers, providers, and caregiving professionals.The operative consequences are symbolic and administrative: the Legislature records its priorities, offers formal recognition for organizing awareness activities, and asks the Chief Clerk to distribute copies.
Implementation—if any—will depend on state agencies, local governments, nonprofits, and health systems choosing to use the resolution as a springboard for events, outreach, or grant applications; the resolution does not attach funding, deadlines, or reporting requirements.Practically, stakeholders most likely to act on the resolution are advocacy groups, clinical centers, and public health departments that can use the Legislative pronouncement in fundraising, awareness campaigns, and program planning. The resolution’s data points (prevalence, diagnosis lag, veteran risk) provide rhetorical and evidentiary support for those efforts but leave operational details to existing institutions and programs.
The Five Things You Need to Know
The measure is a concurrent resolution—symbolic only; it does not create new legal rights, regulatory duties, or direct appropriations.
The resolution cites an estimated 2,400 Californians living with ALS at any time and roughly 5,600 U.S. diagnoses per year to justify the awareness designation.
It explicitly affirms five legislative priorities: (1) timely access to treatments, (2) identifying causes and risk factors, (3) empowering individuals with ALS, (4) reducing physical/emotional/financial burdens, and (5) ensuring high-quality services and supports.
The text singles out military veterans as having a significantly higher likelihood of ALS and therefore signals veteran-focused outreach as a likely policy emphasis.
The only administrative step the resolution requires is that the Chief Clerk of the Assembly transmit copies to the author for distribution; no state agency is assigned implementation duties or reporting obligations.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Summarizes the medical and epidemiological facts about ALS
This section collects the medical description of ALS, life-expectancy statistics, prevalence estimates, diagnostic delays, the share of genetically linked cases, and the projected global increase in ALS cases. For practitioners, these findings are the evidence the Legislature is using to justify the awareness proclamation—useful context for grant writers, public health planners, and researchers seeking legislative rationale for programs.
Designates a month for ALS awareness
This is the core operative line: the Legislature proclaims May 2025 as Amyotrophic Lateral Sclerosis Awareness Month in California. As a concurrent resolution, the proclamation is ceremonial—intended to encourage events, recognition, and public education rather than to require agency action or create statutory entitlements.
Lists five policy commitments for attention and advocacy
The resolution sets out five specific areas where the Legislature expresses commitment: accelerating access to treatments, identifying risk factors and causes, empowering patients, reducing burdens of living with ALS, and ensuring quality services for patients and caregivers. These affirmations are not binding mandates but serve as a checklist stakeholders can cite when requesting funding, program changes, or policy attention.
Commends stakeholders and orders distribution of the resolution
The Legislature formally commends family members, caregivers, volunteers, researchers, providers, and caregiving professionals working on ALS. The only ministerial requirement is that the Chief Clerk transmit copies of the concurrent resolution to the author for appropriate distribution—an administrative step that supports outreach but imposes no implementation obligations on any state department.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People living with ALS in California — the public recognition and compiled data can increase visibility, strengthen advocacy campaigns, and support grant applications that benefit patient services.
- Caregivers and family members — heightened awareness can lead to more community recognition, potential fundraising, and increased availability of volunteer and respite resources spotlighted during awareness activities.
- ALS advocacy and research organizations — the resolution provides legislative backing they can cite to mobilize donors, coordinate awareness events, and press for programmatic support or research funding.
- Veterans’ outreach programs — the specific reference to elevated veteran risk can justify targeted outreach and grant proposals within veteran health networks.
- Neuromuscular clinics and providers — increased awareness often drives earlier referrals and diagnosis, which can affect clinical workloads, care pathways, and participation in clinical trials.
Who Bears the Cost
- State and local public health offices that choose to participate — they may incur modest personnel and event costs if they respond to the proclamation with campaigns or materials, without any dedicated funding from this resolution.
- Nonprofit advocacy groups — expectations to organize events or capitalize on the proclamation may impose opportunity costs and administrative work to coordinate statewide activities.
- Health systems and specialty clinics — a likely increase in referrals or outreach activity may require staffing adjustments and resource allocation to manage demand for diagnostics, supportive devices, or case management.
- Legislative staff — preparing materials, coordinating with stakeholders, and responding to constituent inquiries linked to the proclamation will consume staff time, albeit at modest scale.
Key Issues
The Core Tension
The bill’s central tension is between symbolic recognition and practical action: a proclamation raises public and institutional attention (valuable to advocacy, fundraising, and outreach) but without budgetary or regulatory teeth it may not change access to care, reduce costs, or shorten diagnostic delays—leaving stakeholders to decide whether awareness alone is sufficient or whether the next step must be concrete legislative or budgetary commitments.
The resolution’s central limitation is its ceremonial form: it records legislative priorities and facts but stops short of any funding authority, regulatory change, or programmatic mandate. That limits immediate, measurable impacts—awareness may rise, but services, access, and research progress depend on separate appropriations or regulatory action.
Stakeholders who treat the resolution as a lever for resource requests will need to translate symbolic support into concrete proposals for agencies or budget committees.
Another implementation challenge is attribution and expectations management. The resolution assembles prevalence and diagnostic-delay statistics; stakeholders may reasonably expect follow-up (targeted screening programs, improved diagnostic pathways, veteran-specific outreach).
Yet the text assigns no responsible agency, timeline, or performance measures. That gap creates a real risk: awareness without a strategy can raise hopes among patients and caregivers that the state has committed resources when it has not.
Finally, the resolution relies on snapshot estimates and projections (e.g., case counts, projected global increases) that may become outdated; advocates should pair the proclamation with current, locally grounded data when seeking programmatic responses.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.